oncolog-was-unable-to-sell-its-assets-since-autumn-of-2012-and-has-ended-up-filing-for-bankruptcy

European cancer firm files for bankruptcy

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Since the autumn of 2012, the board of ONCOlog has worked to find buyers for the sale of the entire company or its assets. However, these efforts have... Read more

even-those-non-diabetic-individuals-who-have-high-blood-sugar-are-prone-to-alzheimer-s

High blood sugar causes Alzheimer’s in non-diabetics

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by the University of Arizona (UA), US, highlighted that elevated blood sugar levels are linked to risk for developing Alzheimer's disease.... Read more

bayer-healthcare-stops-phase-ii-trial-of-haemophilia-a-and-b-drug-bay-86-6150-after-detecting-neutralizing-antibody-led

Bayer stops haemophilia trial amidst drug safety concern...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety... Read more

good-news-for-sleep-apnea-patients-fisher-paykel-launches-its-next-generation-flow-generator-range-f-p-icon

F&P ICON+ flow generator to treat sleep apnea better

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fisher & Paykel Healthcare has introduced F&P ICON+, the next generation of its flow generator range for use in the treatment of obstructive sleep apnea... Read more

good-news-for-bird-flu-patients-a-new-dna-sequencing-technique-developed-by-taiwan-s-national-chiao-tung-university-nctu-can-sequence-a-viral-genome-in-just-one-hour-instead-of-one-day

Ultra-fast DNA sequencer to detect bird flu

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A team of scientists from the National Chiao Tung University (NCTU), Hsinchu City, Taiwan, developed a rapid, precise and economical technique for single-molecule... Read more

pharmabcine-uses-avacta-analytical-optim-1000-microvolume-protein-analysis-instrument-to-complete-formulation-and-stability-studies

PharmAbcine uses Avacta instrument for R&D

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at Korean biotech company PharmAbcine are completing formulation and stability studies based on Optim 1000 microvolume protein analysis and... Read more

patrys-cancer-drug-gives-hope-to-patients

Patrys cancer drug gives hope to patients

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the mechanism by which it occurs... Read more

chinese-and-hong-kong-researchers-develop-map-of-avian-influenza-h7n9-comprising-of-bird-migration-patterns-and-estimations-of-poultry-production-and-consumption

Chinese, Hong Kong scientists map H7N9 risk infection

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Novartis: Lucentis reduces AMD blindness by 50%

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209 abstracts from other organizations at the... Read more

the-acquisition-combines-inviragen-s-expertise-in-viral-vaccine-r-d-and-takeda-s-resources-product-development-expertise-and-global-reach

Takeda to acquire Inviragen for $250 mn

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million, and future payments of up to $215 million,... Read more

concert-pharma-and-celgene-s-strategic-collaboration-is-directed-towards-deuterium-modified-compounds-targeting-cancer-and-inflammation

Concert Pharma, Celgene enter in $300 mn merger

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deuterium-modified compounds targeting cancer... Read more

aeras-oxford-university-okairos-get-usd2

Bill Gates pays $2.9mn for TB, malaria, HIV vaccine

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aeras, a nonprofit biotech firm that is advancing TB vaccines, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell... Read more

japan-based-irom-holdings-will-acquire-18

Japanese I’rom acquires 18% in Australian IDT

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading... Read more

in-the-line-of-fire-pawan-bansal-s-family-run-pharma-business-may-now-be-under-scanner

Pawan Bansal's family-run pharma firm also involved in scams?...

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: It seems like the troubles for India's Union Cabinet Minister for Railways, Mr Pawan Kumar Bansal, may not have subsided yet. Although the case of Mr... Read more

prof-sirirurg-songsivilai-of-national-nanotechnology-center-nanotec-thailand-says-that-the-government-will-spend-usd70-million-to-promote-development-of-medical-robots-and-regenerative-medicine

Thailand to spend $70mn to develop medical robots

  • Thailand
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Thailand, which has been leading delegations and participating as an exhibitor in BIO International Convention for the past several years, emerged as... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X